Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease
Clinical trial NCT00925301 · COMPLETED
Trial details
- NCT number
- NCT00925301
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-23
- Primary completion
- 2012-06-12
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.